Stock Analysis on Net

Medtronic PLC (NYSE:MDT)

Present Value of Free Cash Flow to the Firm (FCFF)

Microsoft Excel

In discounted cash flow (DCF) valuation techniques the value of the stock is estimated based upon present value of some measure of cash flow. Free cash flow to the firm (FCFF) is generally described as cash flows after direct costs and before any payments to capital suppliers.


Intrinsic Stock Value (Valuation Summary)

Medtronic PLC, free cash flow to the firm (FCFF) forecast

US$ in millions, except per share data

Microsoft Excel
Year Value FCFFt or Terminal value (TVt) Calculation Present value at 9.52%
01 FCFF0 5,007
1 FCFF1 5,076 = 5,007 × (1 + 1.37%) 4,635
2 FCFF2 5,196 = 5,076 × (1 + 2.36%) 4,332
3 FCFF3 5,370 = 5,196 × (1 + 3.36%) 4,088
4 FCFF4 5,605 = 5,370 × (1 + 4.36%) 3,896
5 FCFF5 5,905 = 5,605 × (1 + 5.36%) 3,748
5 Terminal value (TV5) 149,682 = 5,905 × (1 + 5.36%) ÷ (9.52%5.36%) 95,010
Intrinsic value of Medtronic PLC capital 115,709
Less: Debt (fair value) 21,777
Intrinsic value of Medtronic PLC common stock 93,932
 
Intrinsic value of Medtronic PLC common stock (per share) $70.74
Current share price $79.19

Based on: 10-K (reporting date: 2023-04-28).

Disclaimer!
Valuation is based on standard assumptions. There may exist specific factors relevant to stock value and omitted here. In such a case, the real stock value may differ significantly form the estimated. If you want to use the estimated intrinsic stock value in investment decision making process, do so at your own risk.


Weighted Average Cost of Capital (WACC)

Medtronic PLC, cost of capital

Microsoft Excel
Value1 Weight Required rate of return2 Calculation
Equity (fair value) 105,150 0.83 11.03%
Debt (fair value) 21,777 0.17 2.20% = 2.53% × (1 – 13.07%)

Based on: 10-K (reporting date: 2023-04-28).

1 US$ in millions

   Equity (fair value) = No. shares of common stock outstanding × Current share price
= 1,327,822,539 × $79.19
= $105,150,266,863.41

   Debt (fair value). See details »

2 Required rate of return on equity is estimated by using CAPM. See details »

   Required rate of return on debt. See details »

   Required rate of return on debt is after tax.

   Estimated (average) effective income tax rate
= (29.50% + 8.30% + 6.80% + 21.00% + 10.30% + 2.50%) ÷ 6
= 13.07%

WACC = 9.52%


FCFF Growth Rate (g)

FCFF growth rate (g) implied by PRAT model

Medtronic PLC, PRAT model

Microsoft Excel
Average Apr 28, 2023 Apr 29, 2022 Apr 30, 2021 Apr 24, 2020 Apr 26, 2019 Apr 27, 2018
Selected Financial Data (US$ in millions)
Interest expense, net 636 553 925 1,092 1,444 1,146
Net income attributable to Medtronic 3,758 5,039 3,606 4,789 4,631 3,104
 
Effective income tax rate (EITR)1 29.50% 8.30% 6.80% 21.00% 10.30% 2.50%
 
Interest expense, net, after tax2 448 507 862 863 1,295 1,117
Add: Dividends to shareholders 3,616 3,383 3,120 2,894 2,693 2,494
Interest expense (after tax) and dividends 4,064 3,890 3,982 3,757 3,988 3,611
 
EBIT(1 – EITR)3 4,206 5,546 4,468 5,652 5,926 4,221
 
Current debt obligations 20 3,742 11 2,776 838 2,058
Long-term debt 24,344 20,372 26,378 22,021 24,486 23,699
Shareholders’ equity 51,483 52,551 51,428 50,737 50,091 50,720
Total capital 75,847 76,665 77,817 75,534 75,415 76,477
Financial Ratios
Retention rate (RR)4 0.03 0.30 0.11 0.34 0.33 0.14
Return on invested capital (ROIC)5 5.55% 7.23% 5.74% 7.48% 7.86% 5.52%
Averages
RR 0.21
ROIC 6.56%
 
FCFF growth rate (g)6 1.37%

Based on: 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27).

1 See details »

2023 Calculations

2 Interest expense, net, after tax = Interest expense, net × (1 – EITR)
= 636 × (1 – 29.50%)
= 448

3 EBIT(1 – EITR) = Net income attributable to Medtronic + Interest expense, net, after tax
= 3,758 + 448
= 4,206

4 RR = [EBIT(1 – EITR) – Interest expense (after tax) and dividends] ÷ EBIT(1 – EITR)
= [4,2064,064] ÷ 4,206
= 0.03

5 ROIC = 100 × EBIT(1 – EITR) ÷ Total capital
= 100 × 4,206 ÷ 75,847
= 5.55%

6 g = RR × ROIC
= 0.21 × 6.56%
= 1.37%


FCFF growth rate (g) implied by single-stage model

g = 100 × (Total capital, fair value0 × WACC – FCFF0) ÷ (Total capital, fair value0 + FCFF0)
= 100 × (126,927 × 9.52%5,007) ÷ (126,927 + 5,007)
= 5.36%

where:

Total capital, fair value0 = current fair value of Medtronic PLC debt and equity (US$ in millions)
FCFF0 = the last year Medtronic PLC free cash flow to the firm (US$ in millions)
WACC = weighted average cost of Medtronic PLC capital


FCFF growth rate (g) forecast

Medtronic PLC, H-model

Microsoft Excel
Year Value gt
1 g1 1.37%
2 g2 2.36%
3 g3 3.36%
4 g4 4.36%
5 and thereafter g5 5.36%

where:
g1 is implied by PRAT model
g5 is implied by single-stage model
g2, g3 and g4 are calculated using linear interpoltion between g1 and g5

Calculations

g2 = g1 + (g5g1) × (2 – 1) ÷ (5 – 1)
= 1.37% + (5.36%1.37%) × (2 – 1) ÷ (5 – 1)
= 2.36%

g3 = g1 + (g5g1) × (3 – 1) ÷ (5 – 1)
= 1.37% + (5.36%1.37%) × (3 – 1) ÷ (5 – 1)
= 3.36%

g4 = g1 + (g5g1) × (4 – 1) ÷ (5 – 1)
= 1.37% + (5.36%1.37%) × (4 – 1) ÷ (5 – 1)
= 4.36%